Neonc Technologies Holdings (NTHI) Enterprise Value (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Enterprise Value of -$138601.0 for Q1 2026, up 97.45% year-over-year from -$70194.8 in Q1 2025, and down 136.0% quarter-over-quarter from -$58729.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Enterprise Value (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Enterprise Value for 3 consecutive years, with -$138601.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 97.45% year-over-year to -$138601.0; the TTM figure through Mar 2026 stood at -$138601.0 (up 97.45% YoY), while the FY2025 annual figure was -$58729.0, up 9.5% from the prior year.
- Enterprise Value slipped to -$138601.0 in Q1 2026 per NTHI's latest filing, from -$58729.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$58729.0 in Q4 2025 and bottomed at -$5.4 million in Q1 2025.
- Historically, Enterprise Value has averaged -$1.2 million across 3 years, with a median of -$131820.0 in 2025.
- Annual changes were most pronounced in 2025 — Enterprise Value increased 9.5% — and 2026, when it surged 97.45%.
- Neonc Technologies Holdings' Enterprise Value stood at -$64893.0 in 2024, then increased by 9.5% to -$58729.0 in 2025, then plunged by 136.0% to -$138601.0 in 2026.
- Business Quant data shows NTHI's Enterprise Value at -$138601.0 in Q1 2026, -$58729.0 in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.97 Mn |
| Mar 31, 2026 | -138,601.00 |
| Dec 31, 2025 | -58,729.00 |
| Sep 30, 2025 | -1.51 Mn |
| Jun 30, 2025 | -125,039.00 |
| Mar 31, 2025 | -5.44 Mn |
| Dec 31, 2024 | -64,893.00 |